{
  "trial_id": "NCT00877890",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, race/ethnicity, baseline HbA1c, body mass index (BMI), duration of diabetes, prior antidiabetic medication use, blood pressure, lipid levels, baseline fasting plasma glucose, baseline postprandial glucose, baseline weight, smoking status, concomitant medications.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Glycosylated hemoglobin (HbA1c)",
          "baseline HbA1c"
        ],
        [
          "Weight",
          "baseline weight"
        ],
        [
          "Background Oral Antidiabetic Agent",
          "prior antidiabetic medication use"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male"
      ],
      "remaining_candidate_features": [
        "race/ethnicity",
        "body mass index (BMI)",
        "duration of diabetes",
        "blood pressure",
        "lipid levels",
        "baseline fasting plasma glucose",
        "baseline postprandial glucose",
        "smoking status",
        "concomitant medications"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Baseline HbA1c, Duration of Diabetes, Concomitant Medications, Systolic Blood Pressure, Diastolic Blood Pressure, Fasting Plasma Glucose,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Glycosylated hemoglobin (HbA1c)",
          "Baseline HbA1c"
        ],
        [
          "Background Oral Antidiabetic Agent",
          "Concomitant Medications"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Weight"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Body Mass Index",
        "Duration of Diabetes",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Fasting Plasma Glucose"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, HbA1c, Diabetes duration, Previous antidiabetic medication, Systolic Blood Pressure, Diastolic Blood Pressure, Total Cholesterol, Triglycerides, HDL Cholesterol, LDL Cholesterol.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Glycosylated hemoglobin (HbA1c)",
          "HbA1c"
        ],
        [
          "Background Oral Antidiabetic Agent",
          "Previous antidiabetic medication"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Weight"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Body Mass Index",
        "Diabetes duration",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Total Cholesterol",
        "Triglycerides",
        "HDL Cholesterol",
        "LDL Cholesterol"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of type 2 diabetes, hemoglobin-specific A1c fraction (HbA1c) at screening, systolic blood pressure, diastolic blood pressure, heart rate, waist circumference, fasting plasma glucose, lipid profile, history of hypertension, history of cardiovascular disease, smoking status, use of oral antidiabetic medications, use of antihypertensive agents, use of lipid-lowering agents.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Glycosylated hemoglobin (HbA1c)",
          "hemoglobin-specific A1c fraction (HbA1c) at screening"
        ],
        [
          "Background Oral Antidiabetic Agent",
          "use of oral antidiabetic medications"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Weight"
      ],
      "remaining_candidate_features": [
        "race",
        "ethnicity",
        "body mass index (BMI)",
        "duration of type 2 diabetes",
        "systolic blood pressure",
        "diastolic blood pressure",
        "heart rate",
        "waist circumference",
        "fasting plasma glucose",
        "lipid profile",
        "history of hypertension",
        "history of cardiovascular disease",
        "smoking status",
        "use of antihypertensive agents",
        "use of lipid-lowering agents"
      ]
    }
  }
}